Core Viewpoint - The company Kewah Bio (002022) has developed a monkeypox nucleic acid detection reagent based on its fluorescence PCR technology platform, which has received EU CE and UK MHRA certifications [1] Group 1: Product Development and Certification - The monkeypox detection reagent can provide results in 40 minutes using a one-tube method [1] - The product specifically detects nucleic acid fragments of the monkeypox virus, enabling rapid identification of the virus [1] - The reagent is currently used in several provincial and municipal disease control centers and customs inspection units in China, and it is also being exported to multiple countries [1] Group 2: Financial Impact - The sales revenue from this product is currently small and has not significantly impacted the company's consolidated revenue [1]